Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
June 30, 2004
Primary Completion Date
November 30, 2004
Study Completion Date
November 30, 2004
Conditions
HealthyRenal Impairment
Interventions
DRUG
Lacosamide tablet
Single dose of 100 mg Lacosamide tablet
Trial Locations (2)
Unknown
1, Cologne
2, Rendsburg
All Listed Sponsors
lead
UCB BIOSCIENCES GmbH
INDUSTRY
NCT01796938 - Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects | Biotech Hunter | Biotech Hunter